Harvard Mental Health Letter

Revisiting the CATIE schizophrenia study

A long-term trial of schizophrenia drugs has found that newer medications are not any more effective than a first-generation drug, but questions have been raised about the parameters of the study.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »